Engineered T cells: the promise and challenges of cancer immunotherapy

AD Fesnak, CH June, BL Levine - Nature reviews cancer, 2016 - nature.com
The immune system evolved to distinguish non-self from self to protect the organism. As
cancer is derived from our own cells, immune responses to dysregulated cell growth present …

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria… - Nature reviews …, 2015 - nature.com
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article …

Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity

M Katoh - International journal of oncology, 2017 - spandidos-publications.com
Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-
differentiation, undergo epigenetic, epithelial-mesenchymal, immunological and metabolic …

[HTML][HTML] EMT, CTCs and CSCs in tumor relapse and drug-resistance

A Mitra, L Mishra, S Li - Oncotarget, 2015 - ncbi.nlm.nih.gov
Tumor relapse and metastasis are the primary causes of poor survival rates in patients with
advanced cancer despite successful resection or chemotherapeutic treatment. A primary …

Epithelial–mesenchymal transition: a new target in anticancer drug discovery

F Marcucci, G Stassi, R De Maria - Nature reviews Drug discovery, 2016 - nature.com
The conversion of cells with an epithelial phenotype into cells with a mesenchymal
phenotype, referred to as epithelial–mesenchymal transition, is a critical process for …

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

J Yu, W Sun, Z Wang, X Liang, F Hua, K Li, X Lv… - Nature …, 2019 - nature.com
The existence of breast cancer stem cells (BCSCs) is a major reason underlying cancer
metastasis and recurrence after chemotherapy and radiotherapy. Targeting BCSCs may …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

Wnt5a signaling in cancer

MS Asem, S Buechler, RB Wates, DL Miller, MS Stack - Cancers, 2016 - mdpi.com
Wnt5a is involved in activating several non-canonical WNT signaling pathways, through
binding to different members of the Frizzled-and Ror-family receptors. Wnt5a signaling is …

ROR1: an orphan becomes apparent

TJ Kipps - Blood, The Journal of the American Society of …, 2022 - ashpublications.org
Since its initial identification in 1992 as a possible class 1 cell-surface receptor without a
known parent ligand, receptor tyrosine kinase–like orphan receptor 1 (ROR1) has stimulated …

[HTML][HTML] Common stemness regulators of embryonic and cancer stem cells

C Hadjimichael, K Chanoumidou… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Pluripotency of embryonic stem cells (ESCs) and induced pluripotent stem cells is regulated
by a well characterized gene transcription circuitry. The circuitry is assembled by ESC …